论文部分内容阅读
目的 :探讨尿囊素铝与替普瑞酮治疗胃炎及消化性溃疡的临床效果差异。方法 :本研究于2013年6月~2014年6月将收治的胃炎及消化性溃疡患者随机分为研究组和对照组,其中研究组采用尿囊素铝治疗,而对照组则采用替普瑞酮进行治疗,对比两组患者治疗效果。结果:针对消化性溃疡患者,研究组治疗总有效率为91.67%,对照组治疗总有效率为68.18%,研究组明显高于对照组,差异显著,具有统计学意义(P<0.05)。针对胃炎患者,研究组治疗总有效率为90%,对照组治疗总有效率为63.64%,研究组明显高于对照组,差异显著,具有统计学意义(P<0.05)。两组患者的不良反应发生率比较无明显差异(x~2=0.56,P>0.05)。结论 :尿囊素铝治疗胃炎及消化性溃疡的临床疗效确切,安全性好,值得临床推广使用。
Objective: To investigate the clinical effects of allantoin aluminum and teprenone on gastritis and peptic ulcer. Methods: The patients with gastritis and peptic ulcer admitted to our hospital from June 2013 to June 2014 were randomly divided into study group and control group, in which the study group treated with allantoin, while the control group treated with tep, Ketone for treatment, comparing the treatment effect of two groups of patients. Results: For patients with peptic ulcer, the total effective rate was 91.67% in the study group and 68.18% in the control group. The study group was significantly higher than the control group, with significant difference (P <0.05). For gastritis patients, the total effective rate of the study group was 90%, the total effective rate of the control group was 63.64%, the study group was significantly higher than the control group, the difference was statistically significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (x ~ 2 = 0.56, P> 0.05). Conclusion: The clinical efficacy of allantoin in the treatment of gastritis and peptic ulcer is accurate, safe and worthy of clinical promotion.